Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

TT701

National Institute for Health and Care Excellence NICE logo

Lilly’s Efient and Sucampo’s Amitiza win NICE backing

Blood clot and constipation drugs recommended for NHS use

- PMLiVE

Lilly steps up cancer immunotherapy research

Agrees development deal with Immunocore

Ashfield team picks up Lilly sales award

Syndicated pharma sales team rewarded with supplier prize

- PMLiVE

Biosimilar Lantus leads CHMP opinions

Boehringer and Lilly’s insulin one of six new medicines recommended for EU approval

- PMLiVE

Destination Discovery – Lilly’s answer to Boehringer’s Syrum?

Lilly launches online drug discovery game

- PMLiVE

ADA: Empagliflozin overcomes FDA concerns

Boehringer and Lilly expect decision on diabetes treatment by end of 2014

- PMLiVE

ADA: Lilly/Boehringer insulin glargine matches Lantus

Biosimilar demonstrates equal efficacy to Sanofi’s big-selling diabetes treatment

- PMLiVE

Lilly launches depression information app

iPhone and Android app Talking Progress aims to strengthen patient-HCP communication

- PMLiVE

Lilly’s Cyramza disappoints in liver cancer

Fails to improve overall survival by significant margin

- PMLiVE

Lilly joins clinical data sharing effort

Will provide access via online platform used by GSK, Boehringer, Roche and more

UK flag

Lilly invests in UK life sciences via biotech fund

Will support work of UK universities

- PMLiVE

Sanofi plans OTC version of Lilly’s Cialis

Deal could see erectile dysfunction drug become available without a prescription once its patents expire

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links